{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:24:37Z","timestamp":1787156677163,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtha.2026.05.019","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:50:51Z","timestamp":1779925851000},"page":"3333-3342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Standardization of Platelet Activation Tests for the Diagnosis of Heparin-Induced Thrombocytopenia: Communication from the ISTH-SSC Subcommittee on Immune-Mediated Platelet Disorders"],"prefix":"10.1016","volume":"24","author":[{"given":"Karina","family":"Althaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamam","family":"Bakchoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Gruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishac","family":"Nazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-8438","authenticated-orcid":false,"given":"Claire","family":"Pouplard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.05.019_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bjh.14603","article-title":"The unique immunological features of heparin-induced thrombocytopenia","volume":"177","author":"Staibano","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood-2016-01-635003","article-title":"How I treat patients with a history of heparin-induced thrombocytopenia","volume":"128","author":"Warkentin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1160\/TH07-06-0401","article-title":"Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories","volume":"98","author":"Price","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jth.15560","article-title":"Multicentre evaluation of 5B9, a monoclonal anti-PF4\/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: communication from the ISTH SSC Subcommittee on Platelet Immunology","volume":"20","author":"Pouplard","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0037-1614536","article-title":"First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4\/heparin ELISA","volume":"81","author":"Eichler","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/jth.14383","article-title":"An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia","volume":"17","author":"Eekels","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V45.3.395.395","article-title":"Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods","volume":"45","author":"Fratantoni","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0038-1651610","article-title":"The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia","volume":"69","author":"Chong","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib11","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1016\/j.thromres.2009.12.001","article-title":"Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies","volume":"125","author":"Morel-Kopp","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.05.019_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/cyto.1170","article-title":"Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia","volume":"46","author":"Vitale","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.jtha.2026.05.019_bib13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1365-2141.1997.2613077.x","article-title":"A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia","volume":"98","author":"Tomer","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1160\/TH09-10-0711","article-title":"Contribution of platelet microparticles generation assay to the diagnosis of type II heparin-induced thrombocytopenia","volume":"103","author":"Mullier","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1365-2141.1996.d01-1944.x","article-title":"A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry","volume":"95","author":"Lee","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib16","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/jcm9041226","article-title":"Detection of Platelet-activating antibodies associated with heparin-induced thrombocytopenia","volume":"9","author":"Tardy","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.05.019_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.24006","article-title":"The platelet serotonin-release assay","volume":"90","author":"Warkentin","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib18","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/jth.13516","article-title":"Subcommittee on Platelet Immulnology. Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH","volume":"14","author":"Morel-Kopp","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib19","first-page":"268","article-title":"Heparin-induced thrombocytopenia: effect of heat inactivation of patient\u2019s serum on functional flow cytometric assay results","volume":"21","author":"\u017deleznik","year":"2023","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtha.2026.05.019_bib20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.2019003582","article-title":"Ticagrelor causes false-negative functional tests for heparin-induced thrombocytopenia","volume":"135","author":"Eekels","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-0038-1656324","article-title":"The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia","volume":"68","author":"White","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.chest.2017.03.050","article-title":"IVIg for treatment of severe refractory heparin-induced thrombocytopenia","volume":"152","author":"Padmanabhan","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.05.019_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2017-08-803031","article-title":"Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange","volume":"131","author":"Jones","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib24","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/jth.15766","article-title":"Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide","volume":"20","author":"Reilly-Stitt","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib25","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.05.019_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12231","article-title":"Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the Platelet Physiology Subcommittee of SSC\/ISTH","author":"Cattaneo","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1160\/TH16-02-0109","article-title":"Risk factors for heparin-induced thrombocytopenia: focus on Fcgamma receptors","volume":"116","author":"Rollin","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2141.2011.08793.x","article-title":"British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function","volume":"155","author":"Harrison","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib29","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/jth.13786","article-title":"5B9, a monoclonal antiplatelet factor 4\/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies","volume":"15","author":"Kizlik-Masson","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/jth.14749","article-title":"Evaluation of functional assays for the diagnosis of heparin induced thrombocytopenia using 5B9, a monoclonal IgG that mimics human antibodies","volume":"18","author":"Vayne","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib31","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v11i11.4760","article-title":"Standardization of HIT diagnostic assays, with K070, a chimeric human\/mouse antibody, mimicking heparin-dependent pathogenic antibodies","volume":"11","author":"Amiral","year":"2023","journal-title":"Med Res Arch"},{"key":"10.1016\/j.jtha.2026.05.019_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/rth2.12240","article-title":"Platelet preparation for function testing in the laboratory and clinic: historical and practical aspects","volume":"3","author":"Hechler","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.transci.2018.10.019","article-title":"An update on evidence based diagnostic and confirmatory testing strategies for heparin induced thrombocytopenia using combined immunological and functional assays","volume":"57","author":"Amiral","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2026.05.019_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.14955","article-title":"Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies","volume":"179","author":"Vayne","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2014-06-580894","article-title":"Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis","volume":"125","author":"Padmanabhan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib36","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jth.13066","article-title":"Distinguishing between anti-platelet factor 4\/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia","volume":"13","author":"Nazi","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjh.20216","article-title":"Anti-PF4 disorders: pathogenesis, diagnosis and treatment","volume":"207","author":"Preece","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2019.11.004","article-title":"Accuracy of heparin-induced platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia","volume":"185","author":"Brodard","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.05.019_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/molecules22040617","article-title":"Functional assays in the diagnosis of heparin-induced thrombocytopenia: a review","volume":"22","author":"Minet","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jtha.2026.05.019_bib40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0038-1648929","article-title":"Crossreactivity studies between sera of patients with heparin associated thrombocytopenia and a new low molecular weight heparin, reviparin","volume":"72","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1537-2995.1994.34594249047.x","article-title":"Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet platelet factor 4\/heparin enzyme-linked immunosorbent assay","volume":"34","author":"Greinacher","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2026.05.019_bib42","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1055\/a-1653-5065","article-title":"Heparin-induced thrombocytopenia diagnosis: a retrospective study comparing heparin-induced platelet activation test to (14) C-serotonin release assay","volume":"5","author":"Gonthier","year":"2021","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2026.05.019_bib43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/biomedicines9040332","article-title":"Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice","volume":"9","author":"Tardy-Poncet","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtha.2026.05.019_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.thromres.2019.05.016","article-title":"Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia","volume":"180","author":"Althaus","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.05.019_bib45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jtha.2023.10.003","article-title":"Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia","volume":"22","author":"Pelzl","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jtha.2023.11.019","article-title":"Diagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology","volume":"22","author":"Zlamal","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MBC.0b013e32835cc17e","article-title":"Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital","volume":"24","author":"Solano","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2026.05.019_bib48","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.3390\/diagnostics13183019","article-title":"A functional assay for the determination of heparin-induced thrombocytopenia via flow cytometry","volume":"13","author":"Skornova","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jtha.2026.05.019_bib49","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1055\/s-0037-1614371","article-title":"A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT)","volume":"82","author":"Jy","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib50","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.thromres.2013.12.009","article-title":"Platelet microparticle generation assay: a valuable test for immune heparin-induced thrombocytopenia diagnosis","volume":"133","author":"Mullier","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.05.019_bib51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ijlh.12475","article-title":"Evaluation of a flow cytometric assay for the confirmation of heparin-induced thrombocytopenia","volume":"38","author":"Mali\u010dev","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ejh.13277","article-title":"Pathogenic heparin-induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry","volume":"103","author":"Cipok","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib53","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1046\/j.1365-2141.2003.04369.x","article-title":"Flow cytometry detection of serotonin content and release in resting and activated platelets","volume":"121","author":"Gobbi","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1600-0609.2001.066004253.x","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia: advantages of a functional flow cytometric test in comparison to the heparin-induced platelet-activation test","volume":"66","author":"Poley","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib55","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH06-05-0242","article-title":"Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood","volume":"96","author":"Toth","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib56","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.05.019_bib57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/ijlh.12136","article-title":"High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin-induced thrombocytopenia antibodies","volume":"36","author":"Garritsen","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.05.019_bib58","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2020008195","article-title":"A prospective, blinded study of a PF4-dependent assay for HIT diagnosis","volume":"137","author":"Samuelson Bannow","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib59","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.chest.2016.02.641","article-title":"A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia\/thrombosis","volume":"150","author":"Padmanabhan","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.05.019_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1160\/TH16-06-0482","article-title":"Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry","volume":"117","author":"Maeda","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib61","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1182\/blood.V87.12.4925.bloodjournal87124925","article-title":"Flow cytometry: a clinical test of platelet function","volume":"87","author":"Michelson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib62","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/jth.15233","article-title":"A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia","volume":"19","author":"Rubino","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib63","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.thromres.2013.06.004","article-title":"Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: a retrospective study","volume":"132","author":"Minet","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.05.019_bib64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ajcp\/aqz013","article-title":"Implementation of whole-blood impedance aggregometry for heparin-induced thrombocytopenia functional assay and case discussion","volume":"152","author":"Jin","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2026.05.019_bib65","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib66","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/bloodadvances.2018023077","article-title":"Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia","volume":"2","author":"Pishko","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.019_bib67","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"Guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.019_bib68","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2015-07-661215","article-title":"Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"127","author":"Nagler","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib69","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1160\/TH15-06-0523","article-title":"Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. a systematic review and meta-analysis","volume":"115","author":"Sun","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.019_bib70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V88.2.410.bloodjournal882410","article-title":"Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia","volume":"88","author":"Amiral","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib71","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2002-02-0620","article-title":"Platelet activation induced by human antibodies to interleukin-8","volume":"101","author":"Regnault","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.019_bib72","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:29:57Z","timestamp":1787153397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626003429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1538783626003429"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.019","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardization of Platelet Activation Tests for the Diagnosis of Heparin-Induced Thrombocytopenia: Communication from the ISTH-SSC Subcommittee on Immune-Mediated Platelet Disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}